THE SPC BLOG

RSS

A niche blog dedicated to the issues that arise when supplementary protection certificates (SPCs) extend patents beyond their normal life

thumbnail

An analysis of the CJEU’s ruling in Teva (C-121/2017) and a proposal for its implementation

thumbnail

C-527/17 ruling is out: No SPCs for CE-marked devices

thumbnail

France - Court of Appeal of Paris refers questions to the CJEU

thumbnail

UK - Truvada SPC does not comply with Article 3(a)

thumbnail

Combination SPCs: shaken and stirred - an article

thumbnail

C-121/17 - Teva ruling out now

thumbnail

Study on SPCs for the Dutch Parliament published

thumbnail

France - ezetimibe and simvastatin combination SPC - Paris Court of Appeal refuses request for preliminary injuction

thumbnail

Switzerland - Truvada and moving away from the "infringement test" for future SPCs for combination products

thumbnail

Carpmaels' "SPC Summer Review" - 14 June 2018

thumbnail

France - Paris Court of First Instance nullifies Truvada SPC

thumbnail

European Commission proposal for manufacturing waiver

thumbnail

GDPR notification

thumbnail

Germany - Gilead's SPC for Truvada nullified by the Federal Patent Court

thumbnail

China - patent term extensions allowable soon?

For more from “THE SPC BLOG” please visit thespcblog.blogspot.com